Skip to content
PICO Portalanswers from OpenAlex

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model

PaperCitations, authors & open-access status

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model is a paper indexed in PICO Portal from OpenAlex.

How many citations does Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model have?

PICO Portalcitation count

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model has 121 citations in the OpenAlex counts PICO Portal stores.

When was Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model published?

PICO Portalyear

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model has 2012 year in the PICO Portal index.

What is the open-access status of Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model?

PICO Portaloa status

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model has bronze oa status in the PICO Portal index.

What is the DOI of Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model?

PICO Portaldoi

The DOI for Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model is on the source record.

What is the PMID of Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model?

PICO Portalpmid

The PMID for Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model is on the source record.

What is the OpenAlex record for Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model?

PICO Portalopenalex

The OpenAlex for Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial